Nursing Care of Patients with Hepatic and Liver Disorders

Liver disorders represent a complex spectrum of conditions that disrupt metabolism, detoxification, coagulation, protein synthesis, and fluid regulation, affecting nearly every body system. Because the liver plays a central role in maintaining homeostasis, dysfunction can rapidly lead to portal hypertension, ascites, encephalopathy, coagulopathy, and multi-organ complications. As nurses, we must recognize that laboratory trends such as bilirubin, INR, albumin, ammonia, and transaminases are not isolated numbers but reflections of progressive hepatic failure. Decompensated liver disease requires vigilant monitoring for bleeding, infection, renal compromise, and neurologic decline. Nursing care focuses on early complication detection, medication safety, fluid regulation, and coordination of multidisciplinary interventions, especially in patients being evaluated for transplantation.

1️⃣ Bilirubin Metabolism & Types of Jaundice 🟡

🔷 📖 Definition & Classification

• Jaundice = yellowing from ↑ bilirubin >2–3 mg/dL (N: 0.2–1.2).

• Unconjugated bilirubin = indirect, lipid-soluble.

• Conjugated bilirubin = direct, water-soluble.

• Prehepatic = hemolysis-driven elevation.

• Hepatocellular = impaired conjugation.

• Posthepatic = obstructive bile flow block.

🔷 🧠 Pathophysiology

• Hemolysis → ↑ unconjugated bilirubin production.

• Hepatocyte damage → ↓ conjugation efficiency.

• Bile duct obstruction → conjugated bilirubin reflux.

• ↑ Direct bilirubin → dark urine.

• ↓ Bile in intestine → pale stool.

• Accumulation → scleral icterus visible.

🔷 🩺 Diagnostics / Clinical Findings

• ↑ total bilirubin (N: 0.2–1.2 mg/dL).

• ↑ indirect bilirubin in hemolysis.

• ↑ direct bilirubin in obstruction.

• ↑ AST/ALT (N: <40 U/L) hepatocellular injury.

• ↑ ALP (N: 44–147 U/L) obstruction marker.

• Pruritus common in obstructive type.

🔷 💊 Management & Nursing Priorities

• Treat underlying hemolysis cause.

• Remove obstruction via ERCP if present.

• Monitor bilirubin trend daily.

• Vitamin K if prolonged INR >1.2 (N: 0.8–1.2).

• Maintain skin integrity from scratching.

• Early recognition prevents encephalopathy.

2️⃣ Portal Hypertension 🩸

🔷 📖 Definition & Risk Factors

• ↑ Portal venous pressure >12 mmHg.

• Most common in liver cirrhosis.

• Chronic hepatitis B or C predisposes.

• Alcoholic liver fibrosis increases resistance.

• Fatty liver disease progression risk.

• Long-standing obstruction worsens pressure.

🔷 🧠 Pathophysiology

• Liver fibrosis → ↑ intrahepatic resistance.

• Blood shunted through collateral vessels.

• Collaterals form esophageal varices.

• Splenic congestion → ↓ platelets.

• ↑ Hydrostatic pressure → ascites formation.

• Chronic congestion → hemorrhoidal dilation.

🔷 🩺 Diagnostics / Clinical Findings

• ↓ platelets <150,000 (N: 150–400k) splenic sequestration.

• ↑ INR >1.2 (N: 0.8–1.2) impaired clotting.

• Ascites with shifting dullness.

• Caput medusae visible abdominal veins.

• Ultrasound shows dilated portal vein.

• Endoscopy confirms varices.

🔷 💊 Management & Nursing Priorities

• Propranolol → ↓ portal pressure.

• Avoid straining → reduce variceal rupture risk.

• Monitor for GI bleeding signs.

• Sodium restriction <2g/day → reduce ascites.

• Diuretics (spironolactone) → fluid control.

• Early intervention prevents hemorrhage.

3️⃣ Ascites & RAAS Activation 💧

🔷 📖 Definition & Risk Factors

• Accumulation of fluid in peritoneal cavity.

• Most common in decompensated cirrhosis.

• Portal hypertension primary driver.

• Hypoalbuminemia reduces oncotic pressure.

• Chronic alcohol use predisposes.

• Advanced hepatitis increases risk.

🔷 🧠 Pathophysiology

• Portal pressure ↑ → fluid transudation.

• ↓ albumin <3.5 g/dL (N: 3.5–5.0).

• ↓ Effective circulating volume → RAAS activation.

• ↑ Aldosterone → sodium retention.

• ↑ Sodium → water retention.

• Progressive abdominal distention develops.

🔷 🩺 Diagnostics / Clinical Findings

• Shifting dullness positive.

• Abdominal girth ↑ progressively.

• ↓ albumin (N: 3.5–5.0 g/dL).

• SAAG ≥1.1 indicates portal cause.

• Hyponatremia <135 (N: 135–145 mEq/L).

• Weight gain from fluid accumulation.

🔷 💊 Management & Nursing Priorities

• Sodium restriction <2g/day.

• Spironolactone blocks aldosterone.

• Add furosemide if needed.

• Large-volume paracentesis if tense ascites.

• IV albumin post-paracentesis prevents shock.

• Daily weight monitoring critical.

4️⃣ Esophageal Varices & Acute Bleeding 🚨

🔷 📖 Definition & Risk Factors

• Dilated submucosal veins in esophagus.

• Caused by chronic portal hypertension.

• Cirrhosis primary underlying cause.

• High portal pressure increases rupture risk.

• Coagulopathy worsens bleeding severity.

• Alcohol intake increases rupture risk.

🔷 🧠 Pathophysiology

• Collateral circulation forms to bypass liver.

• Veins thin-walled, fragile, prone to rupture.

• Sudden pressure spike → variceal rupture.

• Massive hemorrhage → hypovolemic shock.

• ↓ perfusion → lactic acidosis.

• High mortality without rapid control.

🔷 🩺 Diagnostics / Clinical Findings

• Hematemesis, bright red blood.

• ↓ hemoglobin <7 g/dL (N: 12–16 F).

• ↓ BP, ↑ HR >100 bpm.

• ↑ lactate >2 mmol/L (N: 0.5–2.0).

• Endoscopy confirms bleeding source.

• ↑ INR >1.2 (N: 0.8–1.2) worsens bleeding.

🔷 💊 Management & Nursing Priorities

• ABC stabilization immediately.

• IV fluids + blood transfusion.

• Octreotide infusion ↓ portal pressure.

• Endoscopic band ligation definitive.

• Balloon tamponade temporary measure.

• ICU monitoring prevents rebleeding.

5️⃣ Hepatic Encephalopathy (HE) 🧠

🔷 📖 Definition & Risk Factors

• Neuropsychiatric dysfunction due to liver failure.

• Caused by accumulation of ammonia (NH₃).

• Precipitated by GI bleeding, infection, constipation.

• High protein load increases ammonia production.

• Hypokalemia worsens ammonia toxicity.

• Advanced cirrhosis major underlying cause.

🔷 🧠 Pathophysiology

• Impaired liver → ↓ ammonia conversion to urea.

• ↑ ammonia >50 µmol/L (N: 15–45) crosses BBB.

• Astrocyte swelling → cerebral edema.

• Neurotransmitter imbalance → confusion.

• Asterixis due to motor cortex dysfunction.

• Severe cases → coma (Grade IV HE).

🔷 🩺 Diagnostics / Clinical Findings

• Altered mental status, confusion present.

• Positive asterixis (flapping tremor).

• ↑ ammonia (N: 15–45 µmol/L).

• ↑ INR >1.2 (N: 0.8–1.2) liver dysfunction.

• Fetor hepaticus = musty breath odor.

• EEG shows triphasic waves.

🔷 💊 Management & Nursing Priorities

• Lactulose → traps ammonia in colon.

• Goal 2–3 soft stools/day.

• Correct hypokalemia (K⁺ N: 3.5–5.0).

• Treat precipitating infection promptly.

• Limit protein during acute episode.

• Monitor LOC hourly if severe.

6️⃣ Lactulose & Rifaximin Mechanism 💊

🔷 📖 Purpose in HE

• Reduce systemic ammonia levels.

• Prevent recurrent encephalopathy episodes.

• Adjunct to cirrhosis management.

• Used long-term in chronic HE.

• Given orally or rectally.

• Monitor stool frequency carefully.

🔷 🧠 Mechanism of Action

• Lactulose acidifies colon → NH₃ → NH₄⁺ trapping.

• Ammonium (NH₄⁺) not absorbed systemically.

• Osmotic effect → diarrhea promotes excretion.

• Rifaximin ↓ gut ammonia-producing bacteria.

• ↓ intestinal bacterial urease activity.

• Combined therapy reduces recurrence risk.

🔷 🩺 Monitoring Parameters

• Target 2–3 loose stools daily.

• Monitor ammonia (N: 15–45 µmol/L) trend.

• Watch for dehydration signs.

• Monitor sodium (N: 135–145) hyponatremia risk.

• Assess mental status improvement.

• Monitor potassium depletion.

🔷 💊 Nursing Considerations

• Hold if severe diarrhea occurs.

• Encourage fluid intake unless restricted.

• Educate family about stool goals.

• Monitor for abdominal cramping.

• Prevent skin breakdown from diarrhea.

• Early treatment prevents cerebral edema.

7️⃣ Viral Hepatitis A–E 🦠

🔷 📖 Transmission Patterns

• HAV → fecal-oral transmission.

• HBV → blood, sexual contact.

• HCV → blood exposure common.

• HDV requires HBV co-infection.

• HEV → fecal-oral, pregnancy risk.

• Chronic infection common in HBV/HCV.

🔷 🧠 Pathophysiology

• Viral replication in hepatocytes.

• Immune-mediated hepatocyte destruction.

• ↑ AST/ALT >40 U/L (N: <40) injury marker.

• Severe cases → fulminant failure.

• Chronic inflammation → fibrosis progression.

• Cirrhosis risk in chronic HBV/HCV.

🔷 🩺 Diagnostics / Clinical Findings

• ↑ ALT > AST in viral injury.

• ↑ bilirubin >1.2 mg/dL (N: 0.2–1.2).

• ↑ PT/INR >1.2 severe dysfunction.

• Positive serologic markers (HBsAg).

• Fatigue, RUQ pain common.

• Dark urine, pale stool possible.

🔷 💊 Management & Nursing Priorities

• Supportive care in HAV.

• Antivirals (tenofovir) in chronic HBV.

• Direct-acting antivirals for HCV.

• Avoid hepatotoxic drugs.

• Monitor LFT trends weekly acute phase.

• Vaccinate close contacts if indicated.

8️⃣ Cirrhosis Pathophysiology 🍷

🔷 📖 Definition & Risk Factors

• Irreversible liver fibrosis, nodular regeneration.

• Chronic alcohol use common cause.

• Chronic hepatitis B/C predisposes.

• Nonalcoholic fatty liver disease progression.

• Autoimmune hepatitis possible cause.

• Long-term toxin exposure increases risk.

🔷 🧠 Pathophysiology

• Chronic injury → stellate cell activation.

• Collagen deposition → fibrosis bands.

• Nodular regeneration disrupts architecture.

• ↑ intrahepatic resistance → portal HTN.

• ↓ albumin synthesis → edema.

• ↓ clotting factor production → bleeding risk.

🔷 🩺 Diagnostics / Clinical Findings

• ↓ albumin <3.5 g/dL (N: 3.5–5.0).

• ↑ bilirubin >1.2 mg/dL (N: 0.2–1.2).

• ↑ INR >1.2 (N: 0.8–1.2).

• ↓ platelets <150k (N: 150–400k).

• Ascites and spider angiomas.

• Ultrasound shows nodular liver surface.

🔷 💊 Management & Nursing Priorities

• Alcohol cessation immediately.

• Manage complications individually.

• Sodium restriction for ascites.

• Beta-blockers reduce variceal risk.

• Monitor LFT and coagulation trends.

• Evaluate for liver transplant candidacy.

9️⃣ Coagulopathy in Liver Disease 🩸

🔷 📖 Definition & Risk Factors

• Impaired clotting due to ↓ hepatic synthesis.

• Liver produces factors I, II, V, VII, IX, X.

• Cirrhosis reduces clotting factor production.

• Vitamin K deficiency worsens dysfunction.

• Chronic cholestasis impairs fat-soluble vitamin absorption.

• Portal hypertension increases bleeding risk.

🔷 🧠 Pathophysiology

• ↓ synthesis of clotting proteins → prolonged PT.

• ↑ INR >1.2 (N: 0.8–1.2) impaired coagulation.

• ↓ platelets <150,000 (N: 150–400k) splenic sequestration.

• ↓ fibrinogen → unstable clot formation.

• Impaired thrombin generation → bleeding tendency.

• Minor trauma may cause severe hemorrhage.

🔷 🩺 Diagnostics / Clinical Findings

• ↑ PT >13 sec (N: 11–13.5 sec).

• ↑ INR >1.2 (N: 0.8–1.2) marker of severity.

• Easy bruising, petechiae present.

• Bleeding gums, epistaxis common.

• ↓ platelets (N: 150–400k).

• ↑ bilirubin suggests worsening liver failure.

🔷 💊 Management & Nursing Priorities

• Administer vitamin K if deficiency suspected.

• Fresh frozen plasma for active bleeding.

• Avoid IM injections → hematoma risk.

• Monitor INR trends closely.

• Apply prolonged pressure after venipuncture.

• Early correction prevents hemorrhagic shock.

🔟 Hepatorenal Syndrome (HRS) 🚰

🔷 📖 Definition & Risk Factors

• Functional renal failure in advanced cirrhosis.

• No intrinsic kidney structural damage.

• Triggered by severe portal hypertension.

• Often follows large-volume paracentesis.

• GI bleeding may precipitate HRS.

• Advanced ascites increases risk.

🔷 🧠 Pathophysiology

• Portal HTN → systemic vasodilation.

• ↓ Effective circulating volume sensed by kidneys.

• RAAS activation → intense renal vasoconstriction.

• ↓ renal perfusion → ↓ GFR.

• ↑ creatinine >1.3 mg/dL (N: 0.6–1.3).

• Progressive oliguria develops.

🔷 🩺 Diagnostics / Clinical Findings

• ↓ urine output <0.5 mL/kg/hr.

• ↑ BUN >20 mg/dL (N: 7–20).

• ↑ creatinine (N: 0.6–1.3) rising trend.

• Normal kidney ultrasound structure.

• No proteinuria or hematuria.

• Hyponatremia <135 (N: 135–145).

🔷 💊 Management & Nursing Priorities

• IV albumin → expand plasma volume.

• Vasoconstrictors (e.g., terlipressin) restore renal flow.

• Avoid nephrotoxic medications.

• Strict I&O monitoring hourly.

• Evaluate for liver transplantation.

• Early intervention slows progression.

1️⃣1️⃣ Fulminant Hepatic Failure ⚠

🔷 📖 Definition & Risk Factors

• Acute liver failure within weeks.

• No prior chronic liver disease.

• Often due to acetaminophen overdose.

• Viral hepatitis may trigger.

• Drug-induced toxicity possible.

• High mortality without transplant.

🔷 🧠 Pathophysiology

• Massive hepatocyte necrosis.

• ↓ clotting factor synthesis → coagulopathy.

• ↑ INR >1.5 (N: 0.8–1.2) diagnostic criterion.

• ↑ ammonia → cerebral edema.

• Impaired glucose regulation → hypoglycemia.

• Multi-organ failure may develop.

🔷 🩺 Diagnostics / Clinical Findings

• Rapid jaundice progression.

• ↑ AST/ALT >1000 U/L (N: <40).

• ↑ bilirubin (N: 0.2–1.2) severe elevation.

• ↓ glucose <70 mg/dL (N: 70–100).

• Altered mental status present.

• Metabolic acidosis possible (pH <7.35).

🔷 💊 Management & Nursing Priorities

• ICU admission immediately.

• Frequent neuro checks for edema.

• Maintain glucose via IV dextrose.

• Correct coagulopathy with FFP.

• Prepare for urgent transplant evaluation.

• Early stabilization improves survival.

1️⃣2️⃣ Acetaminophen Toxicity & N-Acetylcysteine 💊

🔷 📖 Definition & Risk Factors

• Most common cause of acute liver failure.

• Toxic dose >7.5 g in adults.

• Chronic alcohol use increases susceptibility.

• Malnutrition lowers glutathione reserves.

• Overdose may be intentional or accidental.

• Delayed treatment worsens necrosis.

🔷 🧠 Pathophysiology

• Acetaminophen metabolized → NAPQI toxin.

• NAPQI detoxified by glutathione normally.

• Overdose → glutathione depletion.

• NAPQI binds hepatocytes → necrosis.

• ↑ AST/ALT >1000 (N: <40) severe injury.

• Metabolic acidosis may develop.

🔷 🩺 Diagnostics / Clinical Findings

• ↑ AST/ALT (N: <40) massive elevation.

• ↑ INR >1.5 (N: 0.8–1.2) indicates severity.

• ↑ bilirubin (N: 0.2–1.2).

• Nausea, RUQ pain early signs.

• Use Rumack-Matthew nomogram.

• Metabolic acidosis (pH <7.35).

🔷 💊 Management & Nursing Priorities

• Administer N-acetylcysteine (NAC) immediately.

• NAC replenishes glutathione stores.

• Early treatment within 8 hours ideal.

• Monitor LFT trends every 6–12 hrs.

• Supportive ICU care if severe.

• Early therapy prevents transplant need.

1️⃣3️⃣ Hepatocellular Carcinoma (HCC) 🧬

🔷 📖 Definition & Risk Factors

• Primary malignant tumor of hepatocytes.

• Strongly associated with chronic HBV/HCV infection.

• Cirrhosis major predisposing condition.

• Chronic alcohol use increases risk.

• Aflatoxin exposure linked to mutation.

• Male predominance, age >50 years.

🔷 🧠 Pathophysiology

• Chronic inflammation → repeated hepatocyte injury.

• Regenerative nodules → dysplasia → carcinoma.

• Tumor invades hepatic vasculature.

• ↑ Portal pressure worsens liver dysfunction.

• Impaired bile flow → jaundice.

• Rapid progression in cirrhotic liver.

🔷 🩺 Diagnostics / Clinical Findings

• ↑ AFP >400 ng/mL (N: <10) suspicious.

• ↑ AST/ALT (N: <40 U/L) mild elevation.

• ↑ bilirubin >1.2 mg/dL (N: 0.2–1.2).

• RUQ pain, weight loss present.

• Ultrasound shows hepatic mass.

• CT/MRI confirms vascular invasion.

🔷 💊 Management & Nursing Priorities

• Surgical resection if localized.

• Liver transplant for selected patients.

• Transarterial chemoembolization for unresectable cases.

• Monitor AFP trends every 3–6 months.

• Pain management without hepatotoxic drugs.

• Early detection improves survival outcomes.

1️⃣4️⃣ Liver Abscess 🦠

🔷 📖 Definition & Risk Factors

• Localized collection of pus in liver.

• Caused by bacterial or amoebic infection.

• Ascending cholangitis common source.

• Immunocompromised patients at higher risk.

• Diabetes predisposes abscess formation.

• Biliary obstruction increases infection risk.

🔷 🧠 Pathophysiology

• Bacterial invasion → localized inflammation.

• Neutrophil infiltration → pus accumulation.

• Capsule formation limits spread initially.

• ↑ Intrahepatic pressure → pain.

• Systemic inflammatory response possible.

• Untreated → rupture into peritoneum.

🔷 🩺 Diagnostics / Clinical Findings

• Fever >38.5°C persistent.

• RUQ tenderness present.

• ↑ WBC >11,000 (N: 4–11k).

• ↑ ALP >147 U/L (N: 44–147).

• CT scan shows hypodense lesion.

• Blood cultures may be positive.

🔷 💊 Management & Nursing Priorities

• Broad-spectrum IV antibiotics immediately.

• Percutaneous drainage under imaging guidance.

• Monitor WBC and CRP trends.

• Maintain strict aseptic technique.

• Assess for signs of rupture.

• Early drainage prevents sepsis.

1️⃣5️⃣ Cholestasis & Pruritus 🟡

🔷 📖 Definition & Risk Factors

• Impaired bile flow from liver to intestine.

• May be intrahepatic or extrahepatic obstruction.

• Common in primary biliary cholangitis.

• Gallstones may obstruct bile ducts.

• Drug-induced cholestasis possible.

• Pregnancy-related cholestasis risk.

🔷 🧠 Pathophysiology

• Bile acids accumulate in bloodstream.

• ↑ direct bilirubin (N: 0–0.3 mg/dL).

• ↓ bile excretion into intestine.

• Fat malabsorption develops.

• Bile salt deposition in skin → pruritus.

• Chronic retention → hepatocyte injury.

🔷 🩺 Diagnostics / Clinical Findings

• Intense pruritus without rash.

• ↑ ALP >147 U/L (N: 44–147).

• ↑ GGT (N: 9–48 U/L) cholestasis marker.

• ↑ direct bilirubin (N: 0–0.3).

• Pale stool, dark urine present.

• Mild ↑ AST/ALT possible.

🔷 💊 Management & Nursing Priorities

• Cholestyramine binds bile acids.

• Ursodeoxycholic acid improves bile flow.

• Fat-soluble vitamin supplementation.

• Keep nails short to prevent excoriation.

• Monitor bilirubin and ALP trends.

• Relieve itching to prevent skin breakdown.

1️⃣6️⃣ Fat-Soluble Vitamin Deficiency (A, D, E, K) 🧴

🔷 📖 Definition & Risk Factors

• Occurs in chronic cholestasis.

• ↓ bile salts → impaired fat absorption.

• Common in cirrhosis and obstruction.

• Prolonged jaundice increases deficiency risk.

• Malnutrition worsens severity.

• Pancreatic insufficiency may coexist.

🔷 🧠 Pathophysiology

• ↓ bile acids → ↓ micelle formation.

• ↓ absorption of vitamins A, D, E, K.

• Vitamin K deficiency → coagulopathy.

• Vitamin D deficiency → osteoporosis.

• Vitamin A deficiency → night blindness.

• Vitamin E deficiency → neuropathy risk.

🔷 🩺 Diagnostics / Clinical Findings

• ↑ INR >1.2 (N: 0.8–1.2) vitamin K deficiency.

• ↓ 25-OH vitamin D <20 ng/mL (N: 30–100).

• Easy bruising, bleeding gums present.

• Bone pain from osteomalacia.

• Night vision difficulty reported.

• Peripheral neuropathy symptoms possible.

🔷 💊 Management & Nursing Priorities

• Supplement fat-soluble vitamins orally or IM.

• Administer vitamin K if INR elevated.

• Encourage moderate sunlight exposure.

• Monitor bone density periodically.

• Assess bleeding risk regularly.

• Early supplementation prevents complications.

1️⃣7️⃣ Spontaneous Bacterial Peritonitis (SBP) 🦠

🔷 📖 Definition & Risk Factors

• Infection of ascitic fluid without perforation.

• Occurs in advanced cirrhosis with ascites.

• Low ascitic protein <1 g/dL increases risk.

• Prior SBP episode predisposes recurrence.

• GI bleeding may trigger bacterial translocation.

• Immunocompromised cirrhotic patients vulnerable.

🔷 🧠 Pathophysiology

• Bacterial translocation from intestine → ascitic fluid.

• ↓ Immune function in cirrhosis impairs clearance.

• Ascitic fluid acts as bacterial growth medium.

• Inflammatory cascade → systemic vasodilation.

• ↑ Risk for hepatorenal syndrome.

• Untreated infection → septic shock.

🔷 🩺 Diagnostics / Clinical Findings

• Fever, abdominal tenderness present.

• Altered mental status possible.

• Ascitic fluid PMN ≥250 cells/mm³ diagnostic.

• ↑ WBC (N: 4–11k) systemic infection.

• ↑ creatinine >1.3 (N: 0.6–1.3) possible renal involvement.

• Paracentesis confirms diagnosis.

🔷 💊 Management & Nursing Priorities

• Start IV cefotaxime immediately.

• IV albumin reduces renal failure risk.

• Monitor urine output ≥0.5 mL/kg/hr.

• Repeat paracentesis if no improvement.

• Prophylactic antibiotics for recurrence prevention.

• Early treatment decreases mortality significantly.

1️⃣8️⃣ Hyponatremia in Cirrhosis 🧂

🔷 📖 Definition & Risk Factors

• Serum sodium <135 mEq/L (N: 135–145).

• Common in advanced portal hypertension.

• Severe ascites increases risk.

• RAAS and ADH activation contribute.

• Excess free water retention primary cause.

• Diuretic overuse may worsen imbalance.

🔷 🧠 Pathophysiology

• Portal HTN → systemic vasodilation.

• ↓ Effective circulating volume sensed.

• ↑ ADH secretion → water retention ↑.

• Dilutional hyponatremia develops.

• Sodium diluted despite total body excess.

• Severe cases → cerebral edema risk.

🔷 🩺 Diagnostics / Clinical Findings

• ↓ Na⁺ <135 (N: 135–145).

• Confusion, lethargy possible.

• Seizures if Na⁺ <120.

• Low serum osmolality <275 mOsm/kg (N: 275–295).

• Ascites and edema present.

• Monitor daily sodium trend.

🔷 💊 Management & Nursing Priorities

• Fluid restriction 1–1.5 L/day.

• Adjust diuretics carefully.

• Avoid rapid sodium correction.

• Monitor neuro status frequently.

• IV hypertonic saline if severe symptoms.

• Slow correction prevents osmotic demyelination.

1️⃣9️⃣ Hepatic Osteodystrophy 🦴

🔷 📖 Definition & Risk Factors

• Bone disease associated with chronic liver disease.

• Related to vitamin D deficiency.

• Cholestasis impairs fat-soluble vitamin absorption.

• Postmenopausal women higher risk.

• Chronic steroid use worsens bone loss.

• Advanced cirrhosis increases severity.

🔷 🧠 Pathophysiology

• ↓ Vitamin D absorption → ↓ calcium absorption.

• ↓ calcium <8.6 mg/dL (N: 8.6–10.2) possible.

• Secondary hyperparathyroidism develops.

• ↑ Bone resorption → osteoporosis.

• Fragility fractures risk ↑.

• Chronic inflammation contributes to bone loss.

🔷 🩺 Diagnostics / Clinical Findings

• ↓ 25-OH vitamin D <20 ng/mL (N: 30–100).

• ↓ Bone mineral density on DEXA scan.

• Back pain from vertebral compression fractures.

• ↑ alkaline phosphatase (N: 44–147) may present.

• Normal inflammatory markers usually.

• Height loss in chronic cases.

🔷 💊 Management & Nursing Priorities

• Vitamin D supplementation.

• Calcium supplementation daily.

• Weight-bearing exercises encouraged.

• Fall prevention strategies implemented.

• Monitor bone density periodically.

• Early prevention reduces fracture risk.

2️⃣0️⃣ Comprehensive Nursing Integration in Advanced Liver Disease 🩺

🔷 📖 Priority Assessment Focus

• Monitor mental status for encephalopathy.

• Assess abdominal girth daily.

• Evaluate for GI bleeding signs.

• Monitor INR (N: 0.8–1.2) trends.

• Check albumin (N: 3.5–5.0 g/dL) levels.

• Strict I&O monitoring.

🔷 🧠 Fluid & Electrolyte Surveillance

• Monitor Na⁺ (N: 135–145).

• Monitor K⁺ (N: 3.5–5.0).

• Monitor creatinine (N: 0.6–1.3).

• Track daily weight changes.

• Assess for edema progression.

• Monitor ABG if severe disease.

🔷 🩺 Safety & Complication Prevention

• Avoid hepatotoxic medications.

• Prevent falls due to confusion.

• Implement bleeding precautions.

• Educate low-sodium diet adherence.

• Vaccinate against HAV, HBV.

• Early referral for transplant evaluation.

🔷 💊 Interprofessional Coordination

• Coordinate with hepatology specialist.

• Dietitian consult for protein balance.

• Pharmacist review for drug dosing.

• Social worker for transplant planning.

• Palliative care if end-stage disease.

• Continuous patient-family education.

✅ Concept 2 Completed – 20 Full Domain